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ABSTRACT
Objective This study aimed to examine how age and 
gender moderate the associations between alcohol use 
disorders (AUD) and several somatic diseases.
Design and setting We performed a retrospective, 
register- based cohort study with 6- year follow- up of 
patients with AUD and the general population. Data 
were acquired from the Norwegian Patient Registry. 
Cox regressions were used to estimate HRs of somatic 
diseases.
Participants Patients with AUD (17 023; 0.4%) were 
compared with the population without AUD (4 271 559; 
99.6%), with adults aged 18 years or older who were 
registered residents of Norway on 1 January 2008.
Main outcomes Dichotomous variables of 12 specific 
somatic diseases (cardiovascular diseases, endocrine, 
nutritional, and metabolic diseases, cancer, and infectious 
diseases) were assessed. Diagnoses were set in specialist 
healthcare services.
Results Patients with AUD, compared with a population 
without AUD, experienced a significantly greater burden of 
all studied somatic diseases. Middle- aged adults with AUD 
had increased risks (p<0.05) for hypertension; ischaemic 
diseases; pulmonary diseases; cerebrovascular diseases; 
malnutrition; metabolic disorders; cancer; and influenza 
and pneumonia than younger and older adults with AUD. 
For most somatic diseases, we found no differences 
between younger versus older adults with AUD, and 
between females versus males with AUD (p>0.05). Males 
with AUD had significantly higher risks for pulmonary 
heart diseases (HR=3.9, 95% CI 3.3 to 4.6) and metabolic 
disorders (HR 4.7, 95% CI 4.5 to 5.0), while females with 
AUD had a significantly higher risk for viral hepatitis 
(HR=4.4, 95% CI 3.8 to 5.1).
Conclusions Age moderated the associations between 
AUD and most somatic diseases, with middle- aged adults 
with AUD having a greater increased risk of somatic 
diseases compared with younger and older adults with 
AUD. Gender only moderated associations between AUD 
and pulmonary heart diseases, metabolic disorders and 
viral hepatitis. This has implications for the prioritisation of 
somatic resources among patients with AUD.
BACKGROUND
Alcohol use disorder (AUD) is one of the 
leading risk factors for premature death and 
disability globally,1 involving several somatic 
diseases.1 2 Literature suggests that this burden 
varies by age and gender, with some studies 
reporting alcohol use is associated with more 
health loss among adolescents and younger 
or middle- aged adults (15–49 years) than 
older, and in males more than in females.1–3 
In contrast, review studies have reported that 
females with AUD alcohol have higher risks 
of developing certain somatic comorbidities 
(eg, cardiovascular diseases (CVDs), diabetes, 
alcoholic liver problems and breast cancer) 
compared with their male counterparts.4
Only a few epidemiological studies have 
investigated how age and gender moderate the 
risks instigated by alcohol on somatic diseases, 
particularly for CVDs like hypertension and 
ischaemic heart diseases.5 6 For instance, a 
large health examination survey conducted 
among men and women (20–69 years old) 
in Japan found that the elevating effect of 
alcohol consumption on blood pressure is 
more prominent in the older population 
than in the young, while the elevating effect 
of alcohol drinking on serum high- density 
Strengths and limitations of this study
 ► This study investigated how age and gender mod-
erated the risks instigated by alcohol use disor-
ders (AUDs) on somatic diseases, by addressing a 
comprehensive spectrum of somatic diseases with 
appropriate measurements and statistical methods.
 ► The use of national registries provided a large study 
population that gave adequate statistical power to 
detect differences across age groups and gender.
 ► We prospectively compared risks of different types 
of somatic diseases between patients with AUD 
compared with a population without AUD.
 ► Due to limited statistical power of analyse, our study 
could not differentiate the risks of somatic diseases 
related to age trends across gender.
 ► The registries do not have information about severity 
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lipoprotein (HDL) cholesterol is not influenced by age.6 
A similar recent study in South Korea revealed less signif-
icant associations of drinking levels with cardiovascular 
risk factors in women than in men.7 In contrast, a register- 
based cohort study in Denmark reported comparable 
higher risks of a wide range of somatic diseases in those 
with alcohol- dependency in both genders.2
A moderating effect of age and gender on the rela-
tionship between alcohol use and somatic diseases is 
not consistent across studies.2 5–7 This could be due to 
differences in the definition of alcohol use (eg, light and 
moderate alcohol intake vs heavy drinkers); differences 
in confounding factors; characteristics of study popula-
tions, study designs and statistical methods. Further, the 
underlying mechanisms explaining the above- stated age- 
specific and gender- specific findings are currently poorly 
understood. Alcohol may have graver health effects in the 
elderly due to changes in metabolism and distribution.8 
There are also biological differences between genders; 
women absorb and metabolise alcohol differently than 
men.9 Women are often physically smaller than men 
and have a smaller fraction of body water and, there-
fore, achieve higher concentration of alcohol faster than 
men. This may also be related to gender differences in 
liver weight in relation to lean body mass.10 The gender- 
specific findings could also stem from psychosociocul-
tural factors (eg, perceived differences in traditional 
gender roles)4 or differences in access to healthcare.11 
Although women tend to seek treatment from mental 
health and primary care more readily than men, they are 
more likely to face barriers to treatment of addiction.11 
However, recent findings indicate that such gender 
differences in AUD and alcohol- attributable somatic 
diseases are converging in many countries, especially in 
young cohorts.3 4
In general, the moderating effects of age and gender 
on alcohol- related somatic diseases remain under- 
researched, both in terms of a comprehensive spec-
trum of somatic diseases, and in terms of appropriate 
methods of measurement. Epidemiological studies 
are therefore needed to assess the varying relationship 
between alcohol and somatic diseases across age groups 
and gender. Such assessment of moderating effects of 
age and gender provides crucial input for healthcare 
professionals in determining and allocating resources 
as well as identifying specific risk factors that may be 
targeted in preventive interventions. It can also further 
help treatment programmes to offer age- specific and 
gender- specific services. The present study thus aims to 
examine the moderating effects of age and gender on 
the relation between AUD and development of a wide 
range of specific somatic diseases (ie, four CVDs; four 
endocrine, nutritional and metabolic diseases; cancer; 
and three infectious diseases) across the life course—




The study is a retrospective, register- based cohort study 
(2008–2016) combining sociodemographic informa-
tion from Statistics Norway and information on somatic 
diseases and mental disorders obtained from the Norwe-
gian Patient Registry (NPR).
Setting, participants
The sampling framework consisted of all individuals aged 
18 years or older who were legal residents in Norway on 
1 January 2008 (N=4 652 365). The (N=22 512) patients 
with AUD were identified during the preceding 2 years 
(2008–2009) and were then followed until the registra-
tion of somatic diseases from 1 January 2010, through 31 
December 2016. Patients who were registered as deceased 
(N=363 783) during the study period (2008–2016) were 
excluded from analysis. The final sample included for 
analysis consisted of 17 023 (0.4%) patients with AUD, 
and 4 271 559 (99.6%) persons without AUD as a compar-
ison (control) group.
Outcomes and explanatory variables
NPR holds data on all registered diagnoses obtained 
during contacts with specialist healthcare services. All 
mental and somatic diagnoses were received during 
outpatient and inpatient contacts with specialist health-
care according to the International Classification of 
Diseases (ICD), 10th Revision between 1 January 2008 
and 31 December 2016. AUD are diagnosed based on 
ICD- 10, chapter V on mental and behavioural disorders. 
Specifically, it includes all alcohol disorders in the F10 
block. AUD diagnoses were provided by psychologists 
or psychiatrists during outpatient and inpatient contacts 
with the specialist mental healthcare service between 
2008 and 2016. The number of participants visits (regis-
tered with AUD) in 2008 was 8832 (0.2%); 11 929 (0.3%) 
in 2009; 13 144 (0.3%) in 2010; 14 006 (0.3%) in 2011; 
14 708 (0.3%) in 2012; 14 944 (0.4%) in 2013; 15 315 in 
2014 (0.4%); 15 903 (0.4%) in 2015, and 16 609 (0.4%) in 
2016. Table 1 presents the dichotomous variables repre-
senting AUD as an explanatory variable, and somatic 
diseases as event outcome variables, including the year of 
diagnosis.
Covariates
Age, gender, mental disorders and level of education 
were used as covariate variables. The age variable (per 1 
January 2008) was first used as a continuous variable, and 
then categorised into three strata: younger adult (18–35 
years), middle- aged adult (26–65 years) and older adult 
(66 and above years). Gender was coded 0 for males and 
1 for females. Mental disorders were diagnosed based on 
ICD- 10, chapter V on mental and behavioural disorders, 
excluding those with AUD. The participants’ highest level 
of education was coded as 0=primary, 1=secondary, and 
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Statistical analysis
χ2 tests were applied to compare differences in the 
proportions of somatic diseases between patients with 
AUD and the general population (see table 2). The Cox 
proportional regression models were applied to estimate 
the risks of somatic diseases (event outcomes) among 
patients with AUD (an independent risk factor). HRs 
with 95% CIs were reported, with calendar time as the 
underlying time axis. A stepwise regression was applied: 
model 0 present unadjusted HR estimates; HR estimates 
in model 1 were adjusted for age, gender, mental disor-
ders and level of education, and HR estimates in models 
2 and 3 present the interaction effects of AUD with age 
and gender, respectively (include both main effects 
and interaction terms; see table 3). Further, stratified 
Cox models were fitted for each group and gender (see 
table 4). Estimates were judged as statistically significant 
when p values≤0.05. Moreover, to determine whether the 
HRs estimates in the stratified Cox models across age 
groups or between males and females were statistically 
significant, the 95% CIs of HRs were compared. If the 
CIs overlapped, the differences between age groups or 
gender would not be statistically significant. If there was 
no overlap, the difference would be significant. The anal-
yses were performed using Stata SE/16.
Patient and public involvement
This was a retrospective registry study; neither the 
patients nor the members of public were not involved in 
the design, data collection, analysis or reporting of our 




The descriptive summary of study population is presented 
in table 2. The proportions of most somatic diseases are 
at least twice as high in patients with AUD compared with 
individuals without AUD, except for cancer (ie, 5.8% 
among those without AUD vs 6.9% among patients with 
AUD). Patients with AUD experienced a higher burden 
of metabolic disorders (16.5%), hypertension (13.6%) 
and chronic lower respiratory diseases (12.8%). The 
mean age at which a first diagnosis of somatic diseases 
occurs shows that patients with AUD were diagnosed at 
much younger age (about 5–15 years earlier) than those 
without AUD, while such age differences were smaller 
for obesity, viral hepatitis and chronic lower respiratory 
diseases. The gender proportions of somatic diseases are 
also more skewed in patients with AUD, with fewer females 
with AUD diagnosed with somatic diseases compared with 
females in the population without AUD.
Moreover, 53% (N=8998) patients with AUD had 
comorbid mental disorders while only 4% (161,064) of 
those without AUD had mental disorders. The proportion 
of patients with AUD with primary and higher education 
were 42% (7061) and 17% (2798), respectively, whereas 
these proportions were 22% (703 467) and 35% (1 140 
724) among those without AUD.
Moderating effects of age and gender
Table 3 presents results (HR with 95% CI) from the Cox 
regression models, where somatic diseases added as an 
event outcome and AUD was added as an explanatory 
independent variable. A stepwise regression model was 
applied: HR estimates in model 0 were unadjusted esti-
mates; model 1 presents estimates that were adjusted to 
age, gender, level of education and mental disorders, and 
models 2 and 3 present adjusted estimates with the inter-
action effects of AUD with age and gender, respectively. 
The adjusted HR estimates in model 1 illustrate that 
the HRs of all somatic diseases were significantly higher 
among patients with AUD, ranging from 1.4- fold for 
obesity (95% CI 1.2 to 1.6) to 6.4- fold for viral hepatitis 
(95% CI 5.8 to 7.1). In model 2, the age and AUD interac-
tion terms indicate that the risk of developing all somatic 
diseases was statistically significantly moderated by age. 
In model 3, the gender and AUD interaction terms show 
that the risk of developing hypertension; pulmonary heart 
diseases; cerebrovascular diseases; metabolic disorders; 
viral hepatitis, and influenza and pneumonia statistically 
significantly moderated by gender. Gender effects for 
ischaemic heart diseases, diabetes mellitus, malnutrition, 
Table 1 ICD- 10 codes and year of diagnosis for 






  AUD F10 2008–2009
Event outcome variables   
  Cardiovascular diseases   
   Hypertensive diseases I10- I19 2010–2016
   Ischaemic diseases I20- I29 2010–2016
   Pulmonary diseases I26- I28 2010–2016
   Cerebrovascular diseases I60- I99 2010–2016
  Endocrine, nutritional and metabolic diseases
   Diabetes mellitus E10- E14 2010–2016
   Malnutrition E40- E46 2010–2016
   Obesity E66 2010–2016
   Metabolic disorders E70- E90 2010–2016
   Cancer C00- C97 2010–2016
  Infectious diseases   
   Viral hepatitis B15- B19 2010–2016
   Influenza and pneumonia J09- J18 2010–2016
   Chronic lower respiratory 
diseases
J40- J47 2010–2016
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obesity and chronic lower respiratory diseases were non- 
statistically significant.
In table 4, we further conducted stratified analyses 
for the statistically significant interaction terms: fitting 
a model for each age group (ie, younger adult (18–35 
years), middle- aged adult (36–65) and older adult (66 and 
above years)) and gender, separately. Such stratified anal-
yses simplify the interpretations of interaction estimates 
in table 3 (models 2 and 3). The HR estimates further 
showed statistically significant variations of such risks 
among patients with AUD depending on age and gender, 
except for obesity and viral hepatitis which presented 
statistically non- significant age and gender effects.
In all types of CVDs, malnutrition, metabolic disor-
ders, cancer, and influenza and pneumonia, and chronic 
lower respiratory diseases, middle- aged adults with AUD 
had significantly higher HRs than older adults with AUD. 
middle- aged adults with AUD had also significantly higher 
HRs for hypertension, cerebrovascular diseases, malnu-
trition, metabolic disorders, influenza and pneumonia, 
and chronic lower respiratory diseases compared with 
younger adults with AUD, whereas the HRs for ischaemic 
and pulmonary heart diseases, obesity, cancer and viral 
hepatitis were not statically significant between younger 
and middle- aged adults with AUD. The differences in 
HRs of most somatic diseases between younger and older 
adults with AUD were not statically significant, except 
for malnutrition and chronic lower respiratory diseases. 
Older adults with AUD had significantly higher HRs for 
malnutrition (4.6, 95% CI 3.9 to 5.5) and chronic lower 
respiratory diseases (3.4, 95% CI 3.1 to 3.8) compared 
with younger adults with AUD. Non- significant age differ-
ences among patients with AUD were documented for 
diabetes and viral hepatitis.
The gender effects showed that males with AUD had 
significantly higher HRs for pulmonary heart diseases 
(3.9, 95% CI 3.3 to 4.6) and metabolic disorders (4.7, 
95% CI 4.5 to 5.0) compared with females with AUD. 
Females with AUD had significantly higher HRs for 
viral hepatitis (4.4, 95% CI 3.8 to 5.1) compared with 
males with AUD. Although we found significant interac-
tions terms of gender for hypertension, cerebrovascular 
diseases and influenza and pneumonia, the stratified 
HRs did not show statistical significance. Moreover, non- 
significant differences in HRs were found for ischaemic 
diseases, malnutrition, obesity and viral hepatitis between 
males and females with AUD.
DISCUSSION
In this large retrospective, register- based national cohort 
study, patients with AUD demonstrated an excessive risk 
for all studied somatic diseases (ie, CVDs, endocrine, 
nutritional, and metabolic diseases, cancer, and infectious 
Table 3 Stepwise Cox regression models showing HRs of somatic diseases and interaction effects of age and gender among 





Model 2 (the interaction 
term between age and 
AUD)
Model 3 (the interaction 
term between gender 
and AUD)
HR (95% CI) HR (95% CI) P value P value
Cardiovascular diseases
  Hypertension 4.6 (4.4 to 4.8) 2.6 (2.5 to 2.7) <0.001 <0.001
  Ischaemic heart diseases 5.5 (5.2 to 5.8) 2.5 (2.4 to 2.6) <0.001 NS
  Pulmonary heart diseases 6.8 (5.9 to 7.8) 3.1 (2.7 to 3.6) <0.001 <0.001
  Cerebrovascular diseases 8.0 (7.5 to 8.5) 3.8 (3.6 to 4.1) <0.001 <0.001
Endocrine, metabolic and 
nutritional diseases
  Diabetes melitius 4.9 (4.6 to 5.2) 1.9 (1.8 to 2.1) <0.001 NS
  Malnutrition 18.3 (16.8 to 20.0) 6.4 (5.8 to 7.1) <0.001 NS
  Obesity 4.8 (4.4 to 5.3) 1.4 (1.2 to 1.6) <0.001 NS
  Metabolic disorders 11.1 (10.6 to 11.5) 4.5 (4.3 to 4.6) <0.001 <0.01
Cancer 2.9 (2.8 to 3.2) 1.9 (1.8 to 2.1) <0.05 NS
Infectious diseases
  Viral hepatitis 35.5 (33.9 to 38.2) 3.3 (3.1 to 3.6) <0.001 <0.05
  Influenza and pneumonia 11.3 (10.7 to 11.9) 4.1 (3.9 to 4.3) <0.001 <0.05
  Chronic lower respiratory 
diseases
9.5 (9.1 to 10.1) 3.5 (3.3 to 3.6) <0.001 NS
Estimates in models 1–3 are adjusted to age, gender, level of education and comorbid mental disorders.
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diseases) compared with the population without AUD 
across all age groups and genders. We found that the 
increased risks of somatic diseases among patients with 
AUD differed depending on age groups, gender and 
types of somatic diseases. For instance, middle- aged adult 
patients with AUD (36–65 years) had increased risks of 
hypertension, cerebrovascular diseases, malnutrition, 
metabolic disorders, influenza and pneumonia, and 
chronic lower respiratory compared with younger and 
older adults with AUD. However, we did not document 
a moderating effect of age for diabetes or viral hepatitis.
In the present study, the adjusted HRs of all somatic 
diseases were higher in patients with AUD than in the 
population without AUD, ranging from 1.4- fold risk for 
cancer to 6.4- fold risk for viral hepatitis. Such exces-
sive risks of somatic diseases are also found in prior 
studies.2 12 Although some studies reported mixed find-
ings whether alcohol dependency increased the risk of 
some somatic diseases (eg, diabetes, and coronary heart 
related diseases),2 12 we consistently identified patients 
with AUD with elevated risks for all somatic diseases 
investigated in the present study. The elevated risks of 
somatic diseases among patients with AUD is commonly 
related to psychiatric comorbidity (ie, major depression, 
bipolar and PTSD),13 14 poor socioeconomic status and 
lifestyle factors (eg, physical inactivity, poor dietary habits 
and smoking),15–17 or consequences of alcohol’s adverse 
effects on the immune system.18 High levels of disparity 
in accessing and using healthcare services19–21 and side 
effects of psychotropic medications might also play a 
pivotal role.13 For instance, the treatment gap for AUD 
is larger than for any other mental disorder, with less 
than 10% treated in Europe or the USA.22 Even simple 
screening measures for obesity and blood pressure are 
very low among substance use disorder patients.15 23 24
The overall increased risks of the majority somatic 
diseases in patients with AUD aged 36–65 years could be 
due to more psychiatric comorbidities compared with 
the general population, and relatively higher utilisation 
of healthcare services compared with older adult patients 
with AUD.25 However, underdiagnoses or under treat-
ment of AUD26 and a higher mortality rate in the older 
age group may contribute to underestimations of risks of 
somatic diseases.27 It could also relate to age differences 
in the frequency and quantity of alcohol drinking, where 
both the frequency of heavy episodic drinking and the 
quantities reported to be drunk decrease by age.28
Furthermore, we found that most somatic diseases do 
not significantly vary between females and males with 
AUD, except for pulmonary heart diseases, metabolic 
Table 4 Age- based and gender- based stratified Cox regression models showing adjusted HRs of somatic diseases among 













  Hypertension 2.3 (1.8 to 2.8) 2.6 (2.4 to 2.7) 2.0 (1.8 to 2.2) 2.7 (2.6 to 2.8) 2.4 (2.2 to 2.6)
  Ischaemic heart 
diseases
2.5 (1.8 to 3.5) 2.5 (2.3 to 2.7) 1.7 (1.5 to 1.9) – –
  Pulmonary heart 
diseases
2.2 (1.4 to 3.5) 3.6 (3.1 to 4.4) 2.1 (1.6 to 2.7) 3.9 (3.3 to 4.6) 1.8 (1.3 to 2.4)
  Cerebrovascular 
diseases
2.8 (2.0 to 3.9) 4.4 (4.0 to 4.8) 2.5 (2.2 to 2.8) 4.0 (3.7 to 4.3) 3.5 (3.1 to 4.0)
Endocrine, metabolic and nutritional diseases
  Diabetes melitius 2.2 (1.8 to 2.6) 1.9 (1.8 to 2.0) 1.6 (1.4 to 1.8) – –
  Malnutrition 2.6 (1.9 to 3.5) 8.4 (7.5 to 9.5) 4.6 (3.9 to 5.5) – –
  Obesity 1.4 (1.2 to 1.6) 1.2 (1.1 to 1.4) 2.1 (1.6 to 2.9) – –
  Metabolic disorders 3.4 (3.0 to 3.8) 4.8 (4.6 to 5.1) 3.5 (3.2 to 3.8) 4.7 (4.5 to 5.0) 4.1 (3.8 to 4.3)
Cancer 1.7 (1.4 to 2.2) 2.1 (1.9 to 2.2) 1.5 (1.3 to 1.6) – –
Infectious diseases
  Viral hepatitis 2.9 (2.6 to 3.3) 3.2 (2.8 to 3.5) 3.2 (2.9 to 3.6) 2.7 (2.5 to 3.0) 4.4 (3.8 to 5.1)
  Influenza and 
pneumonia
3.1 (2.7 to 3.7) 4.6 (4.3 to 4.9) 3.2 (2.9 to 3.6) 4.3 (4.0 to 4.6) 3.7 (3.4 to 4.1)
  Chronic lower 
respiratory diseases
2.4 (2.1 to 2.7) 3.6 (3.4 to 3.8) 3.4 (3.1 to 3.8) – –
Age- specific HR estimates are adjusted to gender, level of education and comorbid mental disorders. Gender- specific HR estimates are 
adjusted to age, level of education and comorbid mental disorders.
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disorders and viral hepatitis. As stated in the Introduction 
section, our finding reflects the convergence in alcohol 
consumption and alcohol- related problems between 
females and males.3 4 Prior studies documented divergent 
findings reporting either a higher risk among males with 
AUD or no gender differences in somatic symptoms and 
diseases4 25 or alcohol- dependent women reported more 
somatic diseases, for example, liver disease9 and CVDs 
(eg, cardiomyopathy and myopathy).29 These gender 
differences may be attributable to differential biological 
mechanisms,9 and a lower utilisation of addiction treat-
ment.11 30 On the other hand, the elevated risks of somatic 
diseases among males with AUD may relate to differences 
in drinking patterns, where men have higher drinking 
levels, earlier onset of problematic alcohol consumption 
and longer duration of problematic consumption than 
women.25 31 Moreover, it could stem from gender differ-
ences in types of beverages, where men frequently drink 
beer and spirits in a larger quantity, while women prefer 
wine.28
This study brings several methodological advantages in 
the use of NPR. First, the coverage of healthcare services 
and the quality of health records in Norway is consid-
ered to be high, which facilitates representativeness and 
reduces selection bias.32 There are, however, also limita-
tions to this approach. As stated above, AUD is hugely 
under treated in specialist healthcare26 and somatic 
disorders are undertreated among those with alcohol 
and substance abuse,33 the first possibly leading to an 
overestimation of the effect, and the latter an underes-
timation. Second, our research is based on clinically set 
diagnosis from specialist care, which may or may not be 
reliable. It is, however, unlikely that there is systematic 
difference between the AUD and non- AUD groups, thus 
making the relative estimates valid. Third, a larger study 
population brings adequate statistical power to detect 
differences across age groups and gender. Finally, we 
prospectively compared risks of different types of somatic 
diseases between patients with AUD compared with the 
population without AUD, as well as applying appropriate 
statistical methods to examine moderating effects of age 
and gender. The main limitation of this study is that, in 
order to ensure the statistical power of analysis, we could 
not differentiate the risks of somatic diseases related to 
age trends across gender, and among specific types of 
cancer. Furthermore, the registries do not have informa-
tion about severity of AUD (eg, volume and frequency 
of consumption); onset and duration of problematic 
alcohol consumption; and estimates were not adequately 
adjusted to potential confounders, that is, lifestyle factors.
Implications
Our findings suggest that the elevated risk of somatic 
diseases reveals that screening for medical problems 
should be more routinely incorporated into addiction 
treatments at primary and secondary healthcare settings. 
This may help to identify somatic problems earlier and 
reduce the development of more severe forms of somatic 
diseases, while simultaneously reducing detrimental 
effects of alcohol consumption on underlying condi-
tions. In particular, our finding imply that preventive and 
treatment programmes should pay greater attention to 
middle- aged adults with AUD.
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